Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: Vyaghradi Kashay Tablet: Drug- Vyaghradi Kashay Tablet
Dose : One tab(500mg)three times a day with luke warm water
Route -Oral
Duration - 7 days (Initially). If RTPCR Not negative in 7
Sponsors
Ministry of AYUSH Govt of India
Eligibility
Inclusion criteria
Inclusion criteria: People who have been tested positive to be infected with SARS-CoV2 virus and presenting with no symptoms or with mild to moderate symptoms. All the patients of age group 18-65 yrs All those who are willing to give written consent for participation in the study
Exclusion criteria
Exclusion criteria: COVID patients with symptoms classified as severe or critical. Persons with severe primary respiratory disease or other pneumonia Pregnant and lactating women Persons with serious complications of diseases such as cancer, heart disease, stroke, disabilities, mental illnesses, etc., and who are considered to be excluded from the study as evaluated by the investigators COVID-19 positive cases participating as subjects in the interventional arm of other COVID-19 clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time taken to be tested negative for SARS-CoV2 in RT-PCR. To Assess the effect of drug in preventing the progression of severity of symptoms.Timepoint: a)RT PCR 7th and 14th Day b)Assessment of clinical recovery at baseline, Daily 7-14 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome- To assess the effect of Vyaghradi Kwath Tab on blood parameters specific to Covid-19. Timepoint: 08-15 days | — |
Countries
India
Contacts
Public ContactDr Nitin Jindal
A and U Tibbia College and Hospital Govt of NCT of Delhi
Outcome results
None listed